poisar

Stocks · News reference

Privia Health Gr Q2 Adj. EPS $0.38 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate

BenzingaBenzinga Newsdesk

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.07 by 442.86 percent. This is a 58.33 percent increase over earnings of $0.24 per share from

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Insights

    Full Transcript: Privia Health Gr Q2 2026 Earnings Call

    Privia Health Gr (NASDAQ:PRVA) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts

  2. Globenewswire IncDelveinsight

    Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

    The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

  3. SEC EDGARSEC EDGAR

    8-K filing — Privia Health Group, Inc. (PRVA)

    Filed: 2026-08-18 AccNo: 0001759655-26-000068 Size: 172 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits